| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hyperbilirubinemia, Neonatal | 11 | 2025 | 17 | 3.550 |
Why?
|
| Infant, Newborn | 49 | 2026 | 842 | 3.370 |
Why?
|
| Phototherapy | 15 | 2025 | 23 | 3.010 |
Why?
|
| Neonatal Sepsis | 4 | 2024 | 4 | 2.560 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 5 | 2026 | 9 | 2.520 |
Why?
|
| Bilirubin | 17 | 2025 | 30 | 2.390 |
Why?
|
| Infant, Premature | 13 | 2026 | 59 | 2.070 |
Why?
|
| Pulmonary Surfactants | 2 | 2026 | 4 | 1.940 |
Why?
|
| Jaundice, Neonatal | 9 | 2022 | 17 | 1.850 |
Why?
|
| Analgesics, Opioid | 3 | 2026 | 258 | 1.680 |
Why?
|
| Humans | 67 | 2026 | 17622 | 1.560 |
Why?
|
| Female | 55 | 2026 | 12715 | 1.530 |
Why?
|
| Sepsis | 4 | 2017 | 64 | 1.480 |
Why?
|
| California | 28 | 2026 | 2433 | 1.440 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2026 | 205 | 1.430 |
Why?
|
| Male | 46 | 2026 | 10014 | 1.390 |
Why?
|
| Opioid-Related Disorders | 2 | 2025 | 185 | 1.350 |
Why?
|
| Risk Assessment | 15 | 2024 | 1093 | 1.190 |
Why?
|
| Pregnancy Complications | 4 | 2025 | 208 | 1.190 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 2 | 2026 | 70 | 1.170 |
Why?
|
| Patient Discharge | 6 | 2026 | 154 | 1.150 |
Why?
|
| Infant | 17 | 2026 | 1228 | 1.030 |
Why?
|
| Infant, Extremely Premature | 2 | 2025 | 4 | 0.990 |
Why?
|
| Retrospective Studies | 26 | 2026 | 2502 | 0.980 |
Why?
|
| Hyperbilirubinemia | 4 | 2016 | 9 | 0.950 |
Why?
|
| Pregnancy | 15 | 2026 | 1565 | 0.940 |
Why?
|
| Infant, Premature, Diseases | 4 | 2013 | 16 | 0.930 |
Why?
|
| Opiate Substitution Treatment | 1 | 2026 | 55 | 0.930 |
Why?
|
| Benzodiazepines | 1 | 2025 | 29 | 0.920 |
Why?
|
| Gestational Age | 13 | 2025 | 119 | 0.900 |
Why?
|
| Anti-Bacterial Agents | 5 | 2024 | 152 | 0.890 |
Why?
|
| Algorithms | 2 | 2026 | 227 | 0.870 |
Why?
|
| Antibiotic Prophylaxis | 2 | 2024 | 14 | 0.860 |
Why?
|
| Cohort Studies | 20 | 2025 | 2502 | 0.830 |
Why?
|
| Hypoxia-Ischemia, Brain | 5 | 2024 | 7 | 0.770 |
Why?
|
| Blood Culture | 2 | 2020 | 6 | 0.770 |
Why?
|
| Neonatal Abstinence Syndrome | 1 | 2022 | 5 | 0.770 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2026 | 380 | 0.750 |
Why?
|
| Respiration, Artificial | 3 | 2026 | 38 | 0.740 |
Why?
|
| Substance-Related Disorders | 1 | 2025 | 417 | 0.670 |
Why?
|
| Intensive Care Units, Neonatal | 7 | 2023 | 38 | 0.660 |
Why?
|
| Premature Birth | 3 | 2022 | 136 | 0.650 |
Why?
|
| Bacteria | 1 | 2020 | 9 | 0.650 |
Why?
|
| Severity of Illness Index | 7 | 2026 | 446 | 0.630 |
Why?
|
| Patient Readmission | 3 | 2022 | 163 | 0.620 |
Why?
|
| Incidence | 10 | 2021 | 1278 | 0.590 |
Why?
|
| Child, Preschool | 6 | 2026 | 1455 | 0.580 |
Why?
|
| Follow-Up Studies | 9 | 2026 | 1157 | 0.570 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2016 | 120 | 0.560 |
Why?
|
| Neoplasms | 3 | 2021 | 457 | 0.550 |
Why?
|
| Logistic Models | 9 | 2025 | 866 | 0.540 |
Why?
|
| Neonatal Screening | 4 | 2025 | 12 | 0.510 |
Why?
|
| Risk Factors | 12 | 2025 | 3291 | 0.490 |
Why?
|
| Child | 8 | 2026 | 2485 | 0.470 |
Why?
|
| Nomograms | 4 | 2016 | 12 | 0.470 |
Why?
|
| Infant, Extremely Low Birth Weight | 1 | 2015 | 4 | 0.460 |
Why?
|
| Intubation, Intratracheal | 1 | 2015 | 6 | 0.460 |
Why?
|
| Thyrotoxicosis | 1 | 2015 | 2 | 0.450 |
Why?
|
| Antithyroid Agents | 1 | 2015 | 3 | 0.450 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2015 | 9 | 0.450 |
Why?
|
| Congenital Abnormalities | 1 | 2015 | 27 | 0.450 |
Why?
|
| Immunization | 1 | 2015 | 71 | 0.440 |
Why?
|
| Hearing | 1 | 2014 | 2 | 0.440 |
Why?
|
| Length of Stay | 6 | 2018 | 182 | 0.430 |
Why?
|
| Executive Function | 1 | 2014 | 28 | 0.430 |
Why?
|
| Intensive Care Units | 4 | 2011 | 105 | 0.430 |
Why?
|
| Child Development | 1 | 2014 | 57 | 0.420 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2013 | 31 | 0.400 |
Why?
|
| Weight Loss | 5 | 2016 | 298 | 0.400 |
Why?
|
| Registries | 1 | 2014 | 475 | 0.370 |
Why?
|
| Hospital Mortality | 4 | 2011 | 135 | 0.370 |
Why?
|
| Adult | 12 | 2026 | 7621 | 0.360 |
Why?
|
| Cross-Sectional Studies | 2 | 2025 | 1295 | 0.350 |
Why?
|
| APACHE | 2 | 2009 | 11 | 0.350 |
Why?
|
| Time Factors | 9 | 2021 | 1038 | 0.340 |
Why?
|
| Kernicterus | 2 | 2025 | 2 | 0.340 |
Why?
|
| Breast Feeding | 4 | 2022 | 119 | 0.330 |
Why?
|
| Infant, Newborn, Diseases | 3 | 2022 | 34 | 0.330 |
Why?
|
| Asthma | 1 | 2013 | 401 | 0.320 |
Why?
|
| Emergency Service, Hospital | 1 | 2013 | 402 | 0.310 |
Why?
|
| Models, Statistical | 2 | 2009 | 171 | 0.300 |
Why?
|
| Multivariate Analysis | 7 | 2018 | 527 | 0.300 |
Why?
|
| Erythroblastosis, Fetal | 1 | 2009 | 1 | 0.300 |
Why?
|
| Brain Damage, Chronic | 1 | 2009 | 2 | 0.300 |
Why?
|
| Intelligence | 1 | 2009 | 9 | 0.300 |
Why?
|
| Cesarean Section | 3 | 2018 | 35 | 0.280 |
Why?
|
| Young Adult | 7 | 2025 | 2538 | 0.280 |
Why?
|
| Postpartum Hemorrhage | 2 | 2018 | 4 | 0.260 |
Why?
|
| Quality Assurance, Health Care | 1 | 2008 | 120 | 0.260 |
Why?
|
| Treatment Outcome | 6 | 2014 | 1161 | 0.250 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2026 | 11 | 0.240 |
Why?
|
| Hypothermia, Induced | 3 | 2015 | 4 | 0.240 |
Why?
|
| Cardiotocography | 2 | 2023 | 2 | 0.240 |
Why?
|
| Databases, Factual | 2 | 2026 | 304 | 0.240 |
Why?
|
| Proportional Hazards Models | 4 | 2016 | 702 | 0.240 |
Why?
|
| Pain Management | 1 | 2025 | 58 | 0.230 |
Why?
|
| Predictive Value of Tests | 6 | 2018 | 346 | 0.220 |
Why?
|
| Decision Support Techniques | 2 | 2017 | 88 | 0.220 |
Why?
|
| Analgesia, Epidural | 1 | 2024 | 4 | 0.220 |
Why?
|
| Streptococcal Infections | 1 | 2024 | 23 | 0.210 |
Why?
|
| Seizures | 2 | 2014 | 28 | 0.210 |
Why?
|
| Prevalence | 3 | 2016 | 830 | 0.200 |
Why?
|
| Longitudinal Studies | 1 | 2026 | 686 | 0.200 |
Why?
|
| Acidosis | 1 | 2023 | 2 | 0.200 |
Why?
|
| Models, Theoretical | 2 | 2017 | 67 | 0.190 |
Why?
|
| Methadone | 1 | 2022 | 13 | 0.190 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2022 | 4 | 0.190 |
Why?
|
| Retinopathy of Prematurity | 1 | 2022 | 3 | 0.190 |
Why?
|
| Confounding Factors (Epidemiology) | 2 | 2016 | 82 | 0.190 |
Why?
|
| Heart Rate, Fetal | 1 | 2022 | 1 | 0.190 |
Why?
|
| Ethnic Groups | 3 | 2016 | 443 | 0.190 |
Why?
|
| Milk, Human | 1 | 2022 | 9 | 0.180 |
Why?
|
| Continental Population Groups | 2 | 2016 | 283 | 0.180 |
Why?
|
| Mothers | 1 | 2023 | 105 | 0.180 |
Why?
|
| Exchange Transfusion, Whole Blood | 4 | 2015 | 5 | 0.170 |
Why?
|
| Delivery, Obstetric | 2 | 2016 | 18 | 0.150 |
Why?
|
| Case-Control Studies | 4 | 2026 | 1107 | 0.150 |
Why?
|
| Propensity Score | 2 | 2016 | 80 | 0.150 |
Why?
|
| Reference Standards | 2 | 2016 | 14 | 0.140 |
Why?
|
| Propionic Acidemia | 1 | 2018 | 1 | 0.140 |
Why?
|
| Obstetric Labor Complications | 1 | 2018 | 11 | 0.140 |
Why?
|
| Critical Care | 2 | 2009 | 64 | 0.140 |
Why?
|
| Intersectoral Collaboration | 1 | 2018 | 13 | 0.140 |
Why?
|
| Computers | 1 | 2017 | 5 | 0.130 |
Why?
|
| International Classification of Diseases | 1 | 2018 | 85 | 0.130 |
Why?
|
| Prenatal Care | 1 | 2018 | 129 | 0.130 |
Why?
|
| Pregnancy Complications, Hematologic | 1 | 2016 | 2 | 0.130 |
Why?
|
| Pregnancy in Diabetics | 1 | 2016 | 18 | 0.120 |
Why?
|
| Spectrophotometry | 1 | 2016 | 1 | 0.120 |
Why?
|
| Calibration | 1 | 2016 | 8 | 0.120 |
Why?
|
| Quality Improvement | 1 | 2018 | 189 | 0.120 |
Why?
|
| Hemoglobins | 1 | 2016 | 37 | 0.120 |
Why?
|
| Anemia | 1 | 2016 | 31 | 0.120 |
Why?
|
| NAV1.1 Voltage-Gated Sodium Channel | 1 | 2015 | 1 | 0.120 |
Why?
|
| Mutation, Missense | 1 | 2015 | 22 | 0.120 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2015 | 7 | 0.120 |
Why?
|
| Bottle Feeding | 1 | 2015 | 7 | 0.110 |
Why?
|
| Methimazole | 1 | 2015 | 2 | 0.110 |
Why?
|
| Propylthiouracil | 1 | 2015 | 2 | 0.110 |
Why?
|
| Medical Records | 2 | 2022 | 91 | 0.110 |
Why?
|
| Brain Diseases | 1 | 2015 | 1 | 0.110 |
Why?
|
| Asphyxia Neonatorum | 1 | 2015 | 2 | 0.110 |
Why?
|
| Transportation of Patients | 1 | 2015 | 4 | 0.110 |
Why?
|
| Body Temperature | 1 | 2015 | 4 | 0.110 |
Why?
|
| Cerebral Palsy | 1 | 2015 | 14 | 0.110 |
Why?
|
| Health Status Disparities | 1 | 2016 | 151 | 0.110 |
Why?
|
| Intensive Care, Neonatal | 1 | 2014 | 4 | 0.110 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 107 | 0.110 |
Why?
|
| Confidence Intervals | 2 | 2018 | 228 | 0.110 |
Why?
|
| Glucosephosphate Dehydrogenase Deficiency | 1 | 2014 | 1 | 0.110 |
Why?
|
| Prognosis | 4 | 2018 | 609 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 319 | 0.100 |
Why?
|
| Autism Spectrum Disorder | 1 | 2016 | 164 | 0.100 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2013 | 6 | 0.100 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2013 | 55 | 0.100 |
Why?
|
| Delivery of Health Care, Integrated | 2 | 2018 | 540 | 0.100 |
Why?
|
| Parturition | 2 | 2023 | 8 | 0.100 |
Why?
|
| Guidelines as Topic | 2 | 2011 | 43 | 0.090 |
Why?
|
| Outcome Assessment (Health Care) | 2 | 2010 | 213 | 0.090 |
Why?
|
| Pre-Eclampsia | 1 | 2012 | 41 | 0.090 |
Why?
|
| Resuscitation Orders | 1 | 2011 | 3 | 0.090 |
Why?
|
| Pregnancy Outcome | 1 | 2012 | 162 | 0.080 |
Why?
|
| Healthcare Disparities | 2 | 2011 | 208 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2016 | 689 | 0.080 |
Why?
|
| Critical Illness | 1 | 2010 | 53 | 0.080 |
Why?
|
| Probability | 1 | 2009 | 70 | 0.080 |
Why?
|
| Coombs Test | 1 | 2009 | 1 | 0.070 |
Why?
|
| Neurologic Examination | 1 | 2009 | 3 | 0.070 |
Why?
|
| Age Factors | 3 | 2017 | 874 | 0.070 |
Why?
|
| Ecchymosis | 1 | 2008 | 1 | 0.070 |
Why?
|
| Term Birth | 1 | 2008 | 9 | 0.070 |
Why?
|
| Ambulatory Care | 1 | 2010 | 228 | 0.070 |
Why?
|
| Multicenter Studies as Topic | 1 | 2008 | 80 | 0.070 |
Why?
|
| Odds Ratio | 1 | 2009 | 631 | 0.070 |
Why?
|
| Intermittent Positive-Pressure Ventilation | 1 | 2007 | 1 | 0.070 |
Why?
|
| Carbon Dioxide | 1 | 2007 | 2 | 0.070 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2007 | 3 | 0.070 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2007 | 4 | 0.070 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2007 | 7 | 0.070 |
Why?
|
| Maternal Age | 2 | 2018 | 74 | 0.060 |
Why?
|
| European Continental Ancestry Group | 3 | 2016 | 470 | 0.060 |
Why?
|
| Middle Aged | 5 | 2011 | 7954 | 0.060 |
Why?
|
| Adolescent | 3 | 2010 | 3625 | 0.060 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2009 | 308 | 0.060 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2026 | 12 | 0.060 |
Why?
|
| Aged | 4 | 2010 | 6223 | 0.060 |
Why?
|
| Analgesia, Obstetrical | 1 | 2024 | 1 | 0.050 |
Why?
|
| Labor, Obstetric | 1 | 2024 | 5 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2018 | 302 | 0.050 |
Why?
|
| Asian Americans | 2 | 2016 | 160 | 0.050 |
Why?
|
| Cerebral Hemorrhage | 1 | 2022 | 12 | 0.050 |
Why?
|
| Uterine Contraction | 1 | 2022 | 1 | 0.050 |
Why?
|
| Fetus | 1 | 2022 | 5 | 0.050 |
Why?
|
| Sex Factors | 2 | 2016 | 599 | 0.050 |
Why?
|
| Epidemiologic Methods | 1 | 2021 | 70 | 0.040 |
Why?
|
| African Continental Ancestry Group | 2 | 2013 | 140 | 0.040 |
Why?
|
| Obesity | 2 | 2018 | 821 | 0.040 |
Why?
|
| United States | 2 | 2022 | 3922 | 0.040 |
Why?
|
| Statistics, Nonparametric | 2 | 2011 | 46 | 0.040 |
Why?
|
| Aged, 80 and over | 3 | 2010 | 1976 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 383 | 0.040 |
Why?
|
| Apgar Score | 1 | 2018 | 5 | 0.040 |
Why?
|
| Blood Coagulation Disorders | 1 | 2018 | 2 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2018 | 197 | 0.030 |
Why?
|
| Hysterectomy | 1 | 2018 | 30 | 0.030 |
Why?
|
| Parity | 1 | 2018 | 57 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2016 | 35 | 0.030 |
Why?
|
| Paternal Age | 1 | 2016 | 9 | 0.030 |
Why?
|
| Recurrence | 1 | 2017 | 166 | 0.030 |
Why?
|
| Hospital Records | 1 | 2016 | 4 | 0.030 |
Why?
|
| Death Certificates | 1 | 2016 | 17 | 0.030 |
Why?
|
| Birth Certificates | 1 | 2016 | 24 | 0.030 |
Why?
|
| Educational Status | 1 | 2016 | 177 | 0.030 |
Why?
|
| Infant Formula | 1 | 2015 | 10 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2014 | 4 | 0.030 |
Why?
|
| Phenobarbital | 1 | 2014 | 2 | 0.030 |
Why?
|
| Hypnotics and Sedatives | 1 | 2014 | 14 | 0.030 |
Why?
|
| Hispanic Americans | 1 | 2016 | 370 | 0.030 |
Why?
|
| African Americans | 1 | 2016 | 429 | 0.030 |
Why?
|
| Watchful Waiting | 1 | 2013 | 22 | 0.030 |
Why?
|
| Age of Onset | 1 | 2013 | 74 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 363 | 0.020 |
Why?
|
| Body Weight | 1 | 2013 | 203 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 144 | 0.020 |
Why?
|
| Linear Models | 1 | 2011 | 204 | 0.020 |
Why?
|
| Insurance Coverage | 1 | 2011 | 99 | 0.020 |
Why?
|
| Health Facility Size | 1 | 2009 | 2 | 0.020 |
Why?
|
| Insurance, Health | 1 | 2011 | 169 | 0.020 |
Why?
|
| Risk Adjustment | 1 | 2009 | 19 | 0.020 |
Why?
|
| Patient Transfer | 1 | 2009 | 25 | 0.020 |
Why?
|
| Bias | 1 | 2009 | 95 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2011 | 603 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2009 | 268 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2009 | 210 | 0.020 |
Why?
|
| Quality Indicators, Health Care | 1 | 2009 | 124 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2011 | 1251 | 0.020 |
Why?
|
| Hospitalization | 1 | 2012 | 831 | 0.020 |
Why?
|